Clinical Trials Directory

Trials / Conditions / Advanced Solid Tumor Malignancies

Advanced Solid Tumor Malignancies

8 registered clinical trials studyying Advanced Solid Tumor Malignancies — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingJSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors
NCT07475559
Jiangsu Alphamab Biopharmaceuticals Co., LtdPhase 1
Not Yet RecruitingLymphocyte Function Testing in Immuno-oncology
NCT07155811
Centre Leon BerardN/A
RecruitingPhase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Sol
NCT06927297
West China HospitalPhase 1
RecruitingHX044,FIH Study in Patients with Advanced Solid Tumor Malignancies
NCT06649708
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.Phase 1 / Phase 2
WithdrawnATI-2231 in Advanced Solid Tumor Malignancies
NCT05791474
Washington University School of MedicinePhase 1
CompletedA Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
NCT02298387
OncoMed Pharmaceuticals, Inc.Phase 1
UnknownPD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies
NCT01522989
Georgetown UniversityPhase 1
CompletedA Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor Malignancies
NCT00996515
New Mexico Cancer Research AlliancePhase 1